![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Reyataz Induction/Maintenance From Boosted to Unboosted: Similar Efficacy and Tolerability of Atazanavir (ATV) Compared to Atazanavir/Ritonavir (ATV/r), each with Abacavir/Lamivudine (ABC/3TC) after Initial Suppression with ABC/3TC + ATV/r: 84 Week Results of the ARIES Trial
|
|
|
Reported by Jules Levin
IAS Capetown July 22 2009
Kathleen Squires, MD
Professor of Medicine, Thomas Jefferson University
Philadelphia, PA
![image002.gif](../images/072209-1/072209-4/image002.gif)
![image004.gif](../images/072209-1/072209-4/image004.gif)
![image006.gif](../images/072209-1/072209-4/image006.gif)
![image008.gif](../images/072209-1/072209-4/image008.gif)
![image010.gif](../images/072209-1/072209-4/image010.gif)
![image012.gif](../images/072209-1/072209-4/image012.gif)
![image014.gif](../images/072209-1/072209-4/image014.gif)
![image016.gif](../images/072209-1/072209-4/image016.gif)
![image018.gif](../images/072209-1/072209-4/image018.gif)
![image020.gif](../images/072209-1/072209-4/image020.gif)
![image022.gif](../images/072209-1/072209-4/image022.gif)
![image024.gif](../images/072209-1/072209-4/image024.gif)
![image026.gif](../images/072209-1/072209-4/image026.gif)
![image028.gif](../images/072209-1/072209-4/image028.gif)
![image030.gif](../images/072209-1/072209-4/image030.gif)
![image032.gif](../images/072209-1/072209-4/image032.gif)
![lastLipid-1.gif](../images/072209-1/072209-4/lastLipid-1.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|